Oral Medications Orlistat and bupropion-naltrexone combinations are oral options at 1,000-10,000 per month, though weight loss outcomes are typically more modest
Another study suggested that DNA damage in adipocytes can disturb secretory function and adipocyte metabolism and activate the p53 signaling pathway, inducing adipose tissue inflammation and insulin resistance
GLP-1 medications are administered as a subcutaneous injection, meaning the medication is injected just beneath the skinnot into muscle or vein
At the maximum 15mg dose, average weight loss reached 22.5%
Watch for dizziness upon standing, excessive fatigue, unusually slow pulse (below 55 bpm), fainting, or a sudden drop in blood pressure readings